← Back to Patent Explorer
US5658551A Expired / Lapsed US ⏱️ 0.0 years remaining

Stable microbubbles suspensions injectable into living organisms

Assignee: Bracco International BV
•
Filing: 1995-06-01
•
Granted: 1997-08-19
•
Expires: 2015-06-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Gas or air filled microbubble suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography. They contain laminarized surfactants and, optionally, hydrophilic stabilizers. The laminarized surfactants can be in the form of liposomes. The suspensions are obtained by exposing the laminarized surfactants to air or a gas before or after admixing with an aqueous phase.

Inventors

  • 👤 Michel Schneider
  • 👤 Daniel Bichon
  • 👤 Philippe Bussat
  • 👤 Jerome Puginier
  • 👤 Eva Hybl-Sutherland

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 12:57
CPC Classifications
A; A61; A61K; A61K49/00; A61K49/22; A61K49/222; A61K49/223; A61K49/227

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 59 words
An injectable composition comprising, as a suspension in an aqueous carrier phase, gas microbubbles of physiologically acceptable, fluorine-containing entrappable gas or a mixture of a fluorine-containing entrappable gas with CO 2 , N 2 or NO 2 stabilized by dissolved or dispersed surfactants at least one of which is a saturated film forming phospholipid in laminar or lamellar form.
Claim 2
Dependent Claim 59 words
An injectable composition comprising, as a suspension in an aqueous carrier phase, gas microbubbles of physiologically acceptable, fluorine-containing entrappable gas or a mixture of a fluorine-containing entrappable gas with CO 2 , N 2 or NO 2 stabilized by dissolved or dispersed surfactants at least one of which is a saturated film forming phospholipid in laminar or lamellar form.
Claim 3
Dependent Claim 13 words
A suspension according to claim 1, wherein said flourine-containing gas is a freon.
Claim 4
Dependent Claim 16 words
A suspension according to claim 1, wherein the average bubble size is less than 50 μm.
Claim 5
Dependent Claim 13 words
A suspension according to claim 3, wherein said bubble size is 0.5-50 μm.
Claim 6
Dependent Claim 13 words
A suspension according to claim 1 in the form of an aqueous suspension.
Claim 7
Dependent Claim 20 words
A suspension according to claim 1, wherein the lamellar phospholipid is in the form of mono- or pluri-molecular membrane layers.
Claim 8
Dependent Claim 14 words
A suspension according to claim 6, wherein the lamellar phospholipid is a saturated phopholipid.
Claim 9
Dependent Claim 22 words
A suspension according to claim 7, wherein the phospholipid is selected from phosphatidic acid, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidyglycerol, phosphatidylinositol, cardiolipin and sphingomyelin.
Claim 10
Dependent Claim 25 words
A suspension according to claim 8, further containing substances selected from dicetylphosphate, cholesterol, ergosterol, phytosterol, sitosterol, lanosterol, tocopherol, propyl gallate, ascorbyl palmitate and butylated hydroxy-toluene.
Claim 11
Dependent Claim 40 words
A suspension according to claim 1, further containing dissolved viscosity enhancers or stabilizers selected from linear and cross-linked poly- and oligo-saccharides, sugars, hydrophilic polymers and iodinated compounds in a weight ratio to the surfactants comprised between about 1:5 to 100:1.
Claim 12
Dependent Claim 30 words
A suspension according to claim 1, further comprising up to 50% by weight of non-laminar surfactants selected from fatty acids, ester and ethers of fatty acids and alcohols with polyols.
Claim 13
Dependent Claim 20 words
A suspension according to claim 11, wherein the polyols are polyalkylene glycols, polyalkylenated sugars and other carbohydrates, and polyalkylenated glycerol.
Claim 14
Dependent Claim 12 words
A suspension according to claim 1 containing 10 7 7-10 8 microbubbles/ml.
Claim 15
Dependent Claim 12 words
A suspension according to claim 1 containing 10 8 -10 9 microbubbles/ml.
Claim 16
Dependent Claim 12 words
A suspension according to claim 1 containing 10 10 -10 11 .
Claim 17
Dependent Claim 16 words
A suspension according to claim 1, wherein the microbubbles also contain 133 Xe or 81 Kr.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-08-18 2001-02-17 2001-08-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-08-18 2005-02-17 2005-08-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-08-18 2009-02-17 2009-08-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag